Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine

Area of Science:

• Oncology
• Molecular Biology
• Genitourinary (GU) Malignancies

Background:

• Precision medicine in oncology relies on molecular profiling of tumor tissue.
• Tumor biopsies are often infeasible due to location, safety concerns, or cost.
• Circulating tumor cells (CTCs) in liquid biopsies offer a minimally invasive alternative for tissue analysis.

Purpose of the Study:

• To review the current status of CTCs in genitourinary (GU) cancer.
• To discuss methodologies for CTC isolation and detection.
• To highlight the role of CTCs as predictive biomarkers and emerging applications in GU malignancies.

Main Methods:

• Review of current literature on CTC isolation and detection techniques.
• Analysis of CTCs as predictive biomarkers in GU cancers.
• Discussion of emerging research and applications of CTC analysis.

Main Results:

• CTCs provide a viable, less invasive source for molecular analysis compared to traditional biopsies.
• CTC analysis holds promise for informing treatment decisions in GU oncology.
• Further research is needed to validate CTCs as reliable biomarkers for cancer progression.

Conclusions:

• CTCs represent a significant advancement in accessing tumor molecular information non-invasively.
• The application of CTCs in GU cancer management is expanding, offering potential for personalized treatment strategies.
• Continued investigation into CTC technologies will enhance their clinical utility in oncology.